Abstract:
The invention concerns a process for the production of a powdered pulmonary surfactant preparation containing a hydrophobic protein serving as a pulmonary surfactant characterized by the fact that an organic solution or suspension containing a hydrophobic protein serving as a pulmonary surfactant and possibly other components is subject to spray drying. Powder preparations are obtained that exhibit very good stability under storage, are easy to reconstitute and which are also suitable for administration by inhalation.
Abstract:
Acides carboxyliques de phénylalkyloxirane de formule générale I:$(8,)$où R1 représente un atome d'hydrogène, un atome d'halogène, un groupe alkyl inférieur, un groupe alkoxy inférieur ou un groupe trifluorométhyl, R2 possède l'une des représentations de R1, A est une liaison simple, un groupe -CH(R6)-CH(R7)- , un groupe CH(R6)-CH(R7)-CH(R8)- ou un groupe -CH(R6)-CH(R7)-CH(R8)-CH(R9)-, R5 représente un atome d'hydrogène ou un groupe alkyl inférieur et l'un des substituants R3, R4, R6, R7, R8 ou R9 représente un groupe alkyl inférieur et les autres représentent des atomes d'hydrogène, et les sels des acides carboxyliques sont de nouveaux composés ayant une action hypoglycémique. Un procédé pour leur préparation et un nouveau procédé de préparation des produits intermédiaires sont décrits.
Abstract:
The invention relates to a device (1) for dosing and dry nebulization of nebulizable material (12) chosen from the group comprising anti- infective agents and immunomodulators, comprising a nebulization channel (3), which has a first attachment piece and a second attachment piece, and a source of compressed carrier gas connected to the first attachment piece via a valve (16) for the purpose of sending a carrier gas pressure pulse into the nebulization channel. The device is characterized in that between the first attachment piece and second attachment piece, and above the nebulization channel, a reservoir (10) open only towards the nebulization channel, which contains the nebulizable material (12), is connected to the nebulizaton channel such that it is gas-tight with respect to the environment, and that, when the valve is closed, a pressure compensation (22) takes place in the nebulization channel and in the reservoir. The invention also relates to a method for dosing and dry nebulization of such a nebulizable material by means of such a device.
Abstract:
Use of oxirancarboxylic acids of formula (I), whereby R1, R2, R3, Y and n have the meanings indicated in the claims for the prevention and/or treatment of illnesses which are associated with an increased cholesterol and/or triglyceride concentration.
Abstract:
The invention relates to a device (1) for dosing and dry nebulization of nebulizable material (12) chosen from the group comprising anti-infective agents and immunomodulators, comprising a nebulization channel (3) , which has a first attachment piece and a second attachment piece, and a source of compressed carrier gas connected to the first attachment piece via a valve (16) for the purpose of sending a carrier gas pressure pulse into the nebulization channel. The device is characterized in that between the first attachment piece and second attachment piece, and above the nebulization channel, a reservoir (10) open only towards the nebulization channel, which contains the nebulizable material (12), is connected to the nebulizaton channel such that it is gas-tight with respect to the environment, and that, when the valve is closed, a pressure compensation (22) takes place in the nebulization channel and in the reservoir. The invention also relates to a method for dosing and dry nebulization of such a nebulizable material by means of such a device.
Abstract:
The invention describes the use of surfactant comprising phospholipids and pulmonary surfactant proteins for the treatment of surgical adhesions.
Abstract:
Use of oxirancarboxylic acids of formula (I), whereby R1, R2, R3, Y and n have the meanings indicated in the claims for the prevention and/or treatment of illnesses which are associated with an increased cholesterol and/or triglyceride concentration.